Alanazi FK[au] - Search Results

Year	Number of Results
2007	1
2008	1
2009	5
2010	8
2011	11
2012	11
2013	13
2014	15
2015	7
2016	10
2017	16
2018	11
2019	9
2020	12
2021	14
2022	7
2023	11
2024	4

1

Systematic review: Nurses' safety attitudes and their impact on patient outcomes in acute-care hospitals.

Alanazi FK, Sim J, Lapkin S. Alanazi FK, et al. Nurs Open. 2022 Jan;9(1):30-43. doi: 10.1002/nop2.1063. Epub 2021 Sep 19. Nurs Open. 2022. PMID: 34538027 Free PMC article. Review.

2

Gene-editing technology, from macromolecule therapeutics to organ transplantation: Applications, limitations, and prospective uses.

Harisa GI, Faris TM, Sherif AY, Alzhrani RF, Alanazi SA, Kohaf NA, Alanazi FK. Harisa GI, et al. Among authors: alanazi fk. Int J Biol Macromol. 2023 Dec 31;253(Pt 5):127055. doi: 10.1016/j.ijbiomac.2023.127055. Epub 2023 Sep 25. Int J Biol Macromol. 2023. PMID: 37758106 Review.

3

Biopharmaceutical applications of nanogold.

Alanazi FK, Radwan AA, Alsarra IA. Alanazi FK, et al. Saudi Pharm J. 2010 Oct;18(4):179-93. doi: 10.1016/j.jsps.2010.07.002. Epub 2010 Jul 24. Saudi Pharm J. 2010. PMID: 24936133 Free PMC article. Review.

4

Technology evaluation: Kollicoat IR.

Fouad EA, El-Badry M, Neau SH, Alanazi FK, Alsarra IA. Fouad EA, et al. Among authors: alanazi fk. Expert Opin Drug Deliv. 2011 May;8(5):693-703. doi: 10.1517/17425247.2011.566266. Epub 2011 Mar 19. Expert Opin Drug Deliv. 2011. PMID: 21417781 Review.

5

Coding Therapeutic Nucleic Acids from Recombinant Proteins to Next-Generation Vaccines: Current Uses, Limitations, and Future Horizons.

Harisa GI, Faris TM, Sherif AY, Alzhrani RF, Alanazi SA, Kohaf NA, Alanazi FK. Harisa GI, et al. Among authors: alanazi fk. Mol Biotechnol. 2023 Aug 14. doi: 10.1007/s12033-023-00821-z. Online ahead of print. Mol Biotechnol. 2023. PMID: 37578574 Review.

6

Targeting cancer using cholesterol conjugates.

Radwan AA, Alanazi FK. Radwan AA, et al. Among authors: alanazi fk. Saudi Pharm J. 2014 Jan;22(1):3-16. doi: 10.1016/j.jsps.2013.01.003. Epub 2013 Jan 31. Saudi Pharm J. 2014. PMID: 24493968 Free PMC article. Review.

7

Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems.

Salem-Bekhit MM, Youssof AME, Alanazi FK, Aleanizy FS, Abdulaziz A, Taha EI, Amara AAAF. Salem-Bekhit MM, et al. Among authors: alanazi fk. Pharmaceutics. 2021 Nov 23;13(12):1984. doi: 10.3390/pharmaceutics13121984. Pharmaceutics. 2021. PMID: 34959266 Free PMC article. Review.

8

An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects.

Harisa GI, Badran MM, Alanazi FK, Attia SM. Harisa GI, et al. Among authors: alanazi fk. Artif Cells Nanomed Biotechnol. 2018 Jun;46(4):669-679. doi: 10.1080/21691401.2017.1354301. Epub 2017 Jul 13. Artif Cells Nanomed Biotechnol. 2018. PMID: 28701048 Review.

9

Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.

Harisa GI, Sherif AY, Youssof AME, Alanazi FK, Salem-Bekhit MM. Harisa GI, et al. Among authors: alanazi fk. AAPS PharmSciTech. 2020 Jun 8;21(5):168. doi: 10.1208/s12249-020-01716-x. AAPS PharmSciTech. 2020. PMID: 32514657 Review.

10

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles.

Harisa GI, Badran MM, Alanazi FK. Harisa GI, et al. Among authors: alanazi fk. Saudi Pharm J. 2017 Jan;25(1):8-17. doi: 10.1016/j.jsps.2015.06.010. Epub 2015 Jul 2. Saudi Pharm J. 2017. PMID: 28223857 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year